tyrosine has been researched along with 8-bromoguanosino-3',5'-cyclic monophosphorothioate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gong, JL; Gu, B; Lan, T; Li, SB; Li, Y; Luo, L; Ma, P; Mu, CY; Tao, AB; Wang, Y; Wang, ZC; Xu, H; Zhou, Y | 1 |
1 other study(ies) available for tyrosine and 8-bromoguanosino-3',5'-cyclic monophosphorothioate
Article | Year |
---|---|
Increased endogenous PKG I activity attenuates EGF-induced proliferation and migration of epithelial ovarian cancer via the MAPK/ERK pathway.
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Epidermal Growth Factor; ErbB Receptors; Female; Humans; MAP Kinase Signaling System; Mice; Ovarian Neoplasms; Phosphorylation; Tyrosine | 2023 |